Literature DB >> 9660507

REM-sleep motor disorder in children.

S H Sheldon1, J Jacobsen.   

Abstract

In 1986, Schenck and coworkers described REM-sleep behavior disorder as a treatable parasomnia affecting older males. This disorder is characterized by intermittent loss of the muscle atonia, which normally characterizes the rapid eye movement (REM) sleep state. Complex motor behaviors occur that are often injurious and are associated with dreaming. We have identified five children who meet the criteria for REM-sleep behavior disorder and describe the clinical and polysomnographic characteristics of these patients, along with corresponding polysomnographic characteristics of matched comparison subjects.

Entities:  

Mesh:

Year:  1998        PMID: 9660507     DOI: 10.1177/088307389801300603

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

Review 1.  Perchance to dream? Primordial motor activity patterns in vertebrates from fish to mammals: their prenatal origin, postnatal persistence during sleep, and pathological reemergence during REM sleep behavior disorder.

Authors:  Michael A Corner; Carlos H Schenck
Journal:  Neurosci Bull       Date:  2015-08-29       Impact factor: 5.203

2.  Characteristics of REM sleep behavior disorder in childhood.

Authors:  Robin Lloyd; Maja Tippmann-Peikert; Nancy Slocumb; Suresh Kotagal
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

Review 3.  Childhood sleep disorders: diagnostic and therapeutic approaches.

Authors:  Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

Review 4.  Non-respiratory indications for polysomnography and related procedures in children: an evidence-based review.

Authors:  Suresh Kotagal; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.